Navigation Links
Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy
Date:5/30/2008

By Improving the Accuracy of Tumor Grading, MapQuant Dx(TM) Genomic Grade

Could Spare Tens of Thousands Chemotherapy Treatments per Year

ASCO Annual Meeting, May 30, 2008 - booth 23128

CHICAGO, May 30 /PRNewswire/ -- Ipsogen SA (Marseilles, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukaemia announced today that it is entering the breast cancer diagnostic market with the European launch of MapQuant Dx(TM) Genomic Grade. MapQuant Dx(TM) Genomic Grade is the very first molecular diagnostic test to accurately measure tumor grade, a consensus indicator of tumor proliferation, risk of metastasis and response to chemotherapy.

Histological tumor grading is considered a decision factor in most national and international guidelines to breast cancer treatment. While it is generally recommended to treat high-grade "grade 3" breast carcinoma with chemotherapy because they are chemosensitive and will often recur otherwise. By contrast, most low-grade "grade 1" tumors should not be treated with chemotherapy because they have a good prognosis and are often chemo-insensitive.

A key clinical issue is how to treat the 50% of breast cancers tested today as uncertain/intermediate "grade 2" by current methods - based on the visual examination of tumor sections under the microscope.

MapQuant Dx(TM) Genomic Grade test directly measures the expression of the 97 genes that best characterize high-grade vs. low-grade tumors. It can resolve these "grade 2" tumors into either "grade 1" or "grade 3" tumors in 80 % of cases.

MapQuant Dx(TM) Genomic Grade test is especially useful when tumor grade information can be decisive for prescribing a chemotherapy. According to most guidelines, this is the case for hormone-sensitive (ER+) node-negative (N-) invasive breast carcinoma.

"In these patients, most grade 2 tumors are treated by chemotherapy and hormonotherapy. It is expected
'/>"/>

SOURCE Ipsogen SA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
2. Smith & Nephew Endoscopy Launches New, Reusable Cannula Line for Hip Arthroscopy
3. Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
4. Shire Launches Nationwide Adult ADHD Mobile Awareness Tour
5. BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign
6. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
7. LifeQuest World Launches Immune System Boosting Supplement to the North American Market
8. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
9. Biocept Launches Noninvasive Prenatal Rh(D) Diagnostic at Annual ACOG Scientific Meeting
10. Better Nutrition Launches 2008 Summer Nutrition Tour
11. HC&B Healthcare Launches HC&B Digital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , AMSTERDA... the world,s,leading publisher of scientific, medi...ounced a major re-launch of Embase, its comprehens...n indexed records from more than 7,000,active, pee...ayed a key role in the advancement of new biomedic...
(Date:11/27/2009)..., , PARIS, November 27 /PRNewswire-Fi... approval to market Oralair(R) in both adults and ...ermany, the first country where,Oralair(R) has bee... Oralair(R) is now registered in Austria, Belg..., France, Germany, Greece, Hungary, Ireland, Italy...
(Date:11/25/2009)..., , BOSTON, Nov. 25 ...he H1N1 virus, genomic data from the 1918 pandemic... the current H1N1 pandemic, today issued its lates...shows that the lethality of the H1N1 ("Swine Flu")... during the virus,s current outbreak in the spring...
(Date:11/25/2009)..., , BEIJING, Nov. 25 /PRNewswi... developer and provider of vaccines, announced tod... to establish Sinovac (Dalian) Vaccine,Technology ...develop, produce,and commercialize human-use vacci...erience in developing and commercializing world-cl...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...- $15 million development milestone payment to Int...ram in Phase 2 -, BRISBANE, Calif., Sept. 2 Inte...InterMune has earned a $15 million,development mil...che for,the hepatitis C virus (HCV) NS3 protease i...t Roche), currently in a Phase 1b clinical trial i...
...SAN MATEO, Calif., Sept. 2 NeurogesX, Inc.,(Nasda... developing and,commercializing novel pain managem...o, President and Chief Executive Officer, is sched...hcare Unplugged Conference in New,York City on Tue...higlieri,Chief Financial Officer, will be availabl...
...BETHESDA, Md., Sept. 2 Micromet, Inc.,(Nasdaq: M...utical company,developing novel, proprietary antib... autoimmune diseases, today announced the appointm...t and Chief Financial Officer.,Mr. Phillips has se...rs,since 2000, and was the chair of the nominating...
Other Biology Technology:InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 3InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 4NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 2NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 3Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 2Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 3Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 4
(Date:11/26/2009)... at last worked out a way of using recordings of b...ulations. This is the first time sound recordings ...accurate estimates of bird species, populations. B...Ecological Society,s Journal of Applied Ecology ,...a major advance in our ability to monitor whale an...
(Date:11/25/2009)....Scientists at the California Institute of Technol...ve emotion-like behavior in the fruit fly, Drosop...be relevant to the relationship between the neurot...ivity disorder (ADHD), are described in the Decemb...ila brain contains only about 20,000 neurons and ...
(Date:11/25/2009)...VEMBER 25, 2009 Soil is the linchpin of the envir...re meet. Despite that, many students see soil as "...re. Soil science educators are challenged with the... the critical importance of soil in the environmen...d earth science teachers at University of Nebraska...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2UN Gathering of Global Experts to Address Current Crisis in Family Planning 50103 1UN Gathering of Global Experts to Address Current Crisis in Family Planning 50103 2Too Few Americans Get HIV Test Early Enough 50100 1Too Few Americans Get HIV Test Early Enough 50100 2Too Few Americans Get HIV Test Early Enough 50100 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 1The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 2The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 4
...shed the findings of a team of scientists at the n...t provides a whole genome analysis of the protein ...ism known as Dictyostelium. , Led by Dr. Janet S...e evolution of kinases, which are enzymes involved...5% of human genes code for protein kinases, and mu...
...earchers and their colleagues have discovered a ne...a cancer-causing virus found in mice. Their findin...fection with a retrovirus that is native to rodent...nts with a rare type of prostate cancer. The patie...romised some of their natural defenses against vir...
...nnesota were successful in using robotic surgery t...sue in pigs. , Using minimally invasive robotic s...lls into the damaged hearts. The cells were "label...be able to see if they engrafted in the pig hearts...six of seven cases. Subsequent MRI studies showed...
Other Biology News:Scientists elucidate the kinome of key model organism 2New human retrovirus originated in mice 2New human retrovirus originated in mice 3New human retrovirus originated in mice 4U of MN uses robotic surgery techniques in cardiac cell therapy research 2
BD FACSArray bioanalyzer from BD Biosciences - Immunocytometry Systems
...capability allows detection of SYBR Green I or FAM... in the second channel including TET, HEX, VIC, a...RT-qPCR and allelic discrimination. DNA Engine the... temperature gradient feature permits simultaneous...
SlideHyb Glass Array Hybridization Buffer #2 from Ambion
Fingerprinting II Informatix Dimensioning Techniques from Bio-Rad
Biology Products: